Publications by authors named "Dimitra S Siachpazidou"
Introduction: Coronavirus disease-19 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic, giving rise to a serious global health threat. Many countries including Greece have seen a two-wave pattern of reported cases, with a first wave in spring and a second in autumn of 2020.
Methods: A cross-sectional seroprevalence study was designed to measure the prevalence of IgG antibodies with a quantitative SARS-CoV-2 IgG lab-based serology test, chemiluminescent microparticle immunoassay, against novel coronavirus in rural areas in Greece after the second pandemic wave.
Background: We aimed to estimate the SARS-CoV-2 antigen and antibody seroprevalence in one of the worst-affected by the pandemic semi-closed communities in Greece, Deskati, and evaluate the sociodemographic and clinical correlations of functional antibody responses.
Methods: The Ag2019n-CoV V1310/V1330 Rapid Test (Prognosis Biotech, Greece) was used for antigen detection. The Rapid Test 2019-nCoV Total Ig, V1210/V1230 (Prognosis Biotech, Greece), and the SARS-CoV-2 IgG II Quant method (Architect, Abbott, Illinois, USA) were used for antibody testing.
Article Synopsis
- Primary care centers play a key role in identifying chronic obstructive pulmonary disease (COPD) among smokers aged 40-65 in Greece, with a study finding a prevalence of 10.6% in a sample of 1,100 people.
- The research showed that 7.5% of participants were newly diagnosed, with women experiencing more severe respiratory and depressive symptoms despite smoking less, while younger patients under 55 had more frequent wheezing and exacerbations compared to older patients.
- Overall, the findings highlight the importance of primary healthcare in early COPD detection, particularly among smokers who may not recognize their symptoms or seek medical help.